Catalyst Wire Dossier Catalyst Wire Dossier

RELiZORB

· Alcresta Therapeutics
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for RELiZORB, covering 2017-01-20 to 2026-02-04. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating the Utility of RELiZORB™ for Treating Feeding Intolerance in Critically Ill Adults With Multi-Organ Failure [NA]

See pricing